UK pharma major GSK on Friday announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has licensed Blenrep (belantamab mafodotin) in combinations with bortezomib plus ...

Alector has announced the completion of enrollment for its Phase II clinical trial, PROGRESS-AD, evaluating the safety and ...

Learn more about whether Amicus Therapeutics, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor grades ...

In the meantime, have a read of Emma Hanrahan’s piece on the Kingspan chief receiving backing from investor advisory firm ...

The property remains under offer, with the parties are still conducting due diligence on the deal, according to reports ...